secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xencor Inc (XNCR)
CIK:        0001326732
Form:       8-K
Filed at:   2025-02-13T23:59:59+00:00
Accession:  0001326732-25-000005
Event type: other_material
Sentiment:  negative
Materiality: 0.90
Item codes: 4.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xencor restates FY2023 and Q1-Q3 2024 results; errors in royalty accounting and tax
--------------------------------------------------------------------------------

- Royalty transaction with OMERS Life Sciences misclassified as deferred income instead of debt; impacted balance sheet by ~$168.5M debt understatement.
- Estimated FY2023 impact: revenue understated by $6.3M, interest expense understated by $5.5M; operating cash flow overstated by $163M.
- Additional tax errors: R&D expense under Section 174 and state tax lead to ~$7.8M shareholder equity overstatement for FY2023.
- Material weaknesses identified in internal control over financial reporting related to both royalty and tax errors.
- RSM US LLP recalls its audit reports on 2023 financials and internal controls; company will file amendments before 2024 10-K.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1326732/000132673225000005/0001326732-25-000005-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1326732/000132673225000005/xncr-20250207.htm
  HTML page:      https://secwatch.observer/filing/0001326732-25-000005

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer